3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Aptevo Therapeutics filed a prospectus supplement under its existing Form S-3 shelf registration covering up to $2,309,834 of common stock to be sold through an at-the-market program with Roth Capital Partners. The company said it had previously sold 303,157 shares for gross proceeds of $11.8 million under the same agreement, so new sales could dilute existing shareholders.
Offering of up to $2,309,834 in common stock under the April 28, 2025 At The Market Offering Agreement with Roth Capital Partners, LLC
Prior sales under the agreement: 303,157 shares for aggregate gross proceeds of $11.8 million
Paul Hastings LLP issued a legal opinion on the shares, filed as Exhibit 5.1
Filing dated October 30, 2026; 8-K signed November 2, 2026
Digital Brands Group received a notice of default on October 29, 2026 from the holder of its unsecured convertible note, which asserts the full note is immediately due at 120% of outstanding amounts. The holder says it will start legal proceedings unless it receives an acceptable extension proposal by the end of October 29, 2026, and the company disputes some of the assertions while evaluating its options.
Note principal is $3,529,412, issued July 23, 2026 under a Securities Purchase Agreement with Shakawe Capital LLC.
Holder cites a missed $1,000,000 partial payment due October 23, 2026 and a registration statement not filed by August 7, 2026.
Holder asserts the Mandatory Default Amount is 120% of outstanding principal, accrued interest and other amounts, with default interest of 20% per annum.
Company disputes certain assertions and says a material adverse effect on liquidity is possible if the note is accelerated or legal proceedings begin.
Oxford Industries amended its $325 million asset-based revolving credit agreement on October 29, 2026, extending the maturity from March 6, 2028 to October 29, 2031. The filing says effective interest rates are unchanged and the amendment adds flexibility for acquisitions, investments and restricted payments, which gives the company a longer runway for its borrowing base.
Maturity extended from March 6, 2028 to October 29, 2031
Facility size is $325 million; effective interest rates remain unchanged
SOFR credit spread adjustment removed from the interest rate calculation
Amendment adds flexibility for acquisition, investment and restricted payment conditions
On October 30, 2026, Essential Properties, L.P., a subsidiary of Essential Properties Realty Trust, issued $517.5 million of senior unsecured exchangeable notes, including $67.5 million from the full exercise of the initial purchasers' option. The notes mature on January 15, 2032, and are exchangeable into the company's common stock at an initial price of about $30.88 per share, with the issuer able to settle in cash, shares, or a combination. For shareholders, this adds significant debt and could lead to future share issuance if the notes are exchanged.
Aggregate principal of $517.5 million, including $67.5 million from the full exercise of the initial purchasers' option
4.375% annual interest, paid semi-annually on January 15 and July 15, beginning July 15, 2027; maturity January 15, 2032
Initial exchange rate of 32.3860 shares per $1,000 principal, or about $30.88 per share
Registration rights agreement requires a resale registration statement to become effective within 180 days
Porch Group and its affiliate Porch Reciprocal Exchange entered an agreement with StoneX Financial to sell shares of Porch common stock from time to time through an at-the-market program. The Reciprocal can sell up to 10 million shares it holds, and the company can issue up to 5 million new shares, which could add to the outstanding share count. Porch receives no proceeds from the Reciprocal's sales, and neither party is required to sell any shares.
Reciprocal may sell up to 10 million shares it currently holds, about 16.2 million shares total
Company may issue and sell up to 5 million new shares; proceeds go to Porch for general corporate purposes
Sales agent is paid a 1.5% cash commission on gross proceeds, plus certain expenses
Shares are offered under Form S-3 Registration No. 333-299730, with the agreement dated October 30, 2026
OpenWorld, Inc. filed an 8-K attaching a legal opinion from its counsel, Harter, Secrest & Emery LLP, on the validity of shares issued and sold in an offering tied to a prospectus supplement. The filing is administrative and does not state offering size, price, or proceeds.
Legal opinion from Harter, Secrest & Emery LLP covers validity of the shares in the offering, attached as Exhibit 5.1
Filing made in connection with a Prospectus Supplement; the 8-K gives no offering size, price, or proceeds
Signed October 30, 2026 by Chief Financial Officer Gerard Hernandez
Rapport Therapeutics closed an underwritten offering of common stock and pre-funded warrants and a $172.5 million offering of 2.25% convertible senior notes due 2032 on October 30, 2026. The company estimates net proceeds of about $215.7 million from the stock offering and $166.8 million from the notes, which it plans to use mainly to fund clinical trials of RAP-219, and it expects these funds plus existing cash to support operations through the end of 2029. Shareholders face dilution from the new shares and the potential conversion of the notes, and the company now carries a new debt obligation.
Stock offering: 8,333,334 firm shares at $21.00 each, plus 1,428,571 option shares exercised in full on October 28, 2026, and pre-funded warrants for up to 1,190,476 shares
Estimated net proceeds of $215.7 million from the stock offering and $166.8 million from the notes
$172.5 million of 2.25% convertible senior notes due December 1, 2032, with an initial conversion price of about $26.7750 per share
Notes offering closed October 30, 2026; the company says proceeds will fund operations through the end of 2029
Xcel Energy entered into a new equity distribution agreement on October 30, 2026, allowing it to sell up to $6.0 billion of common stock through sales agents, including forward sale arrangements. The filing also terminated its prior at-the-market program dated May 1, 2026, while forward sale agreements from earlier programs remain outstanding, so shareholders should note the potential for additional shares to be issued.
Up to $6.0 billion aggregate gross sales price of common stock (par value $2.50 per share) under the new Equity Distribution Agreement dated October 30, 2026
Prior at-the-market program dated May 1, 2026 was terminated; about $448.6 million of shares remained unsold at termination
About $3.8 billion of shares remain subject to outstanding forward sale agreements from the prior program, and about $2.2 billion from an August 1, 2025 agreement
Xcel Energy will not initially receive proceeds from borrowed shares sold under forward agreements; proceeds are expected on future physical settlement
On October 29, 2026, Public Storage and its subsidiary PSOC agreed to sell $500 million of senior notes due November 15, 2036, through underwriters led by BofA Securities, BNP Paribas and Morgan Stanley. The company expects to use the net proceeds to repay commercial paper and to partly repay $650 million of PSOC's 1.500% notes due 2026 at maturity. The notes add new debt, and the offering is expected to close on November 6, 2026, subject to customary conditions.
$500 million senior notes due November 15, 2036, bearing interest at 5.600% a year, issued by PSOC and guaranteed by Public Storage
Notes issued at 98.293% of par value; interest paid semi-annually on May 15 and November 15, starting May 15, 2027
Proceeds to repay amounts under PSOC's $1.0 billion commercial paper program and partly repay $650 million of 1.500% notes due 2026
U.S. Bancorp filed a Certificate of Designations on October 29, 2026 to create its Series P Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, then closed the sale of 1,000,000 depositary shares on October 30, 2026. Each depositary share represents 1/25th of a share of the preferred stock, and the preferred has a $25,000 liquidation preference per share. The filing is a financing disclosure with no stated effect on reported results, but it adds a new class of senior equity ahead of common shareholders.
Certificate of Designations for Series P preferred stock filed October 29, 2026
Sale of 1,000,000 depositary shares closed October 30, 2026; each represents 1/25th of a preferred share
Preferred stock carries a $25,000 liquidation preference per share
Underwriters include U.S. Bancorp Investments, Barclays Capital and Morgan Stanley & Co.; U.S. Bank Trust Company is depositary
Procter & Gamble closed an underwritten public offering of four series of notes totaling $4.0 billion on October 30, 2026, issued under its existing Form S-3 shelf registration. The filing discloses only the offering terms and attached legal opinions, and does not state the use of proceeds.
$750 million of 5.125% notes due October 30, 2031, and $750 million of 5.300% notes due October 30, 2033
$1.25 billion of 5.450% notes due October 30, 2036, and $1.25 billion of 5.900% notes due October 30, 2056
Issued under Registration Statement on Form S-3 (Registration No. 333-299472)
Legal opinions from Travonte Warren and Fried, Frank, Harris, Shriver & Jacobson LLP are filed as exhibits
Enova International and certain subsidiaries amended their secured asset-backed revolving credit facility with Bank of Montreal as administrative agent through a Fourth Amendment dated October 30, 2026. The amendment increases the total commitment from $825 million to $900 million, giving the company $75 million more in committed borrowing capacity under the facility.
Total commitment under the revolving credit facility increases from $825 million to $900 million
Amendment dated October 30, 2026, is the Fourth Amendment to the Amended and Restated Credit Agreement
Bank of Montreal serves as administrative agent and collateral agent
Full agreement will be filed as an exhibit to the Form 10-K for the year ending December 31, 2026
Norwegian Cruise Line Holdings' subsidiary NCL Corporation signed two credit facility agreements on October 27, 2026, providing up to approximately $2.5 billion for each of two new cruise vessels, for total borrowing capacity of about $5 billion. The loans are backed by Italian state export credit agency SACE, which insures 100% of the loans subject to conditions, and the filing does not report any effect on the company's earnings or results.
Two facilities signed October 27, 2026, each up to approximately $2.5 billion, for Vessel 1 (delivery 2034) and Vessel 2 (delivery 2036)
Floating rate of six-month Term SOFR plus a 0.90% margin, with customary agency, structuring and commitment fees
Loans repaid in twenty-four equal semi-annual installments beginning six months after each ship's delivery; guaranteed by NCL Corporation
Facilities fund 80% of delivery payments under the shipbuilding contracts and are insured by SACE, subject to conditions
Albemarle entered a $1.5 billion unsecured revolving credit facility on October 29, 2026, with JPMorgan Chase Bank, N.A. as administrative agent, and terminated its 2022 credit agreement, which was scheduled to mature in October 2028. The company also adopted amended bylaws effective immediately, under which shareholders owning at least 20% of outstanding shares can request a special meeting.
$1.5 billion unsecured revolving credit facility, maturing October 29, 2031, with variable interest rates tied to a benchmark rate plus a margin based on credit ratings
Financial covenant requires a Consolidated Leverage Ratio of no more than 3.50:1.00 at each fiscal quarter end, with an optional 0.50:1.00 increase for four quarters after certain debt-financed acquisitions over $500 million
Existing 2022 credit agreement with Bank of America, N.A. as agent terminated October 29, 2026; it was scheduled to mature October 28, 2028
Bylaws amended and restated October 26, 2026 to let shareholders owning at least 20% of outstanding shares request a special meeting
Remitly Global entered into Amendment No. 2 to its credit agreement on October 26, 2026, increasing its secured revolving credit facility from $550 million to $1 billion and its letter of credit sub-facility from $200 million to $400 million. The company expects to use the facility mainly to support prefunding of customer flows in its global remittance business and for general corporate purposes.
Secured revolving credit facility increased from $550 million to $1 billion
Letter of credit sub-facility increased from $200 million to $400 million
Amendment dated October 26, 2026; JPMorgan Chase Bank, N.A. serves as agent
Proceeds expected to support prefunding of customer flows and general corporate purposes
Arch Reinsurance Ltd., a subsidiary of Arch Capital Group, signed Amendment No. 6 to its letter of credit facility with Lloyds Bank Corporate Markets on October 28, 2026. The amended facility provides for $700 million for letters of credit, extends the availability period to May 31, 2027, and raises the maximum incremental commitment to $200 million from $50 million. The filing describes a financing arrangement that adjusts borrowing capacity for the company's insurance operations, and it does not report any change to earnings or guidance.
Facility provides for $700 million for letters of credit under the amended agreement.
Availability period end date extended from May 31, 2026 to May 31, 2027.
Maximum incremental commitment increased from $50 million to $200 million.
Amendment also extends letters of credit for the 2027 underwriting year of account.
Allarity Therapeutics terminated its Common Stock Purchase Agreement with Tumim Stone Capital LLC on October 28, 2026, which had allowed the company to sell up to $6.0 million of newly issued common stock to Tumim at its discretion. The company said it chose to end the agreement to pursue alternative financing arrangements, and it will not sell further shares to Tumim under it.
Agreement dated January 28, 2026, allowed sales of up to $6.0 million of newly issued common stock to Tumim.
Termination effective October 28, 2026; the company says no early termination penalty is payable.
Indemnification and certain expense obligations survive termination.
The company plans to pursue alternative financing arrangements; the filing does not name them.
Walker & Dunlop entered into Amendment No. 1 to its existing credit agreement with JPMorgan Chase Bank, N.A. as administrative agent, dated October 26, 2026. The amendment increases revolving credit commitments from $50 million to $150 million and letter of credit commitments from $25 million to $75 million, giving the company more borrowing capacity under its credit facility.
Revolving credit commitments increased from $50 million to $150 million
Letter of credit commitments increased from $25 million to $75 million
Amendment dated October 26, 2026, amends the Amended and Restated Credit Agreement dated March 14, 2025
JPMorgan Chase Bank, N.A. serves as administrative agent; some lenders have other financial relationships with the company
Prologis entered into a new Equity Distribution Agreement on October 30, 2026, allowing it to sell up to $5 billion of common stock through an at-the-market offering. The agreement replaces its existing at-the-market program dated May 5, 2020, and the shares will be sold under an effective shelf registration statement. The filing does not state any shares sold so far, and it creates a mechanism that could dilute existing shareholders depending on how much stock is issued.
Maximum aggregate offering price of up to $5,000,000,000 of common stock, par value $0.01 per share
Agreement dated October 30, 2026, with Prologis, L.P. as co-party and a group of sales agents and forward purchasers
Replaces the equity distribution agreement dated May 5, 2020
Shares sold under shelf registration Form S-3 (No. 333-289636), effective August 15, 2025
American Express issued $3.0 billion of senior notes on October 30, 2026, in three tranches: $1.5 billion of 5.447% fixed-to-floating notes due 2030, $1.15 billion of 5.817% fixed-to-floating notes due 2034, and $350 million of floating rate notes due 2030. The notes were sold under a prospectus supplement dated October 26, 2026 and an existing senior indenture, so the filing reports routine debt financing rather than a change in operations. The filing does not state how the proceeds will be used.
Total principal issued: $3.0 billion across three tranches dated October 30, 2026
$1.5 billion of 5.447% fixed-to-floating rate notes due October 30, 2030
$1.15 billion of 5.817% fixed-to-floating rate notes due October 27, 2034, plus $350 million of floating rate notes due October 30, 2030
Mammoth Energy Services subsidiaries Cobra Aviation Services and Leopard Aviation signed a $58.0 million senior secured term loan agreement with Bank7 on October 28, 2026, to finance or reimburse aircraft acquisitions. No amounts were advanced at closing, and Term Loan B depends on further conditions, so the facility's effect on shareholders will depend on future borrowings and covenant compliance.
Facility splits into a $25.0 million Term Loan A and a $33.0 million Term Loan B; no amounts were advanced at closing.
Term Loan B becomes available only after Bank7 sells at least $10.0 million of participation interests and Term Loan A is fully advanced.
Interest is the greater of 6.25% or the Wall Street Journal prime rate plus 0.50%; loans mature October 26, 2030.
Mammoth guarantees the obligations; it must hold at least $25.0 million of unencumbered liquid assets at each fiscal quarter end, and Cobra must meet a 1.25 to 1.00 debt service coverage ratio starting December 31, 2026.
Repligen plans to issue $1.0 billion of 0.25% convertible senior notes due 2031, with about $541.4 million issued in exchange for $456.8 million of its 1.00% notes due 2028 and about $458.6 million sold for cash. The company says it will use about $120.0 million of the cash proceeds to repurchase common stock at $188.64 per share, and closing is expected on or about November 6, 2026. For shareholders, the deal refinances part of the 2028 notes and could lead to up to 5,301,100 new shares on conversion, while the related share repurchases could affect the stock price.
Exchange: about $456.8 million of 2028 notes swapped for about $541.4 million of new notes; the company receives no cash from this part.
Cash sale: about $458.6 million of new notes sold for cash, with about $120.0 million used to repurchase shares at $188.64.
Initial conversion price is about $226.37, a 20.0% premium to the October 29, 2026 last sale price; up to 5,301,100 shares could be issued on conversion.
Closing is expected on or about November 6, 2026; about $143.2 million of 2028 notes will remain outstanding.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.